GlobeImmune, Inc.
GBIM
$0.0002
$0.000.00%
OTC PK
| 03/31/2016 | 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | |
|---|---|---|---|---|---|
| Revenue | 6.21M | 6.46M | 6.92M | 5.28M | 5.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.21M | 6.46M | 6.92M | 5.28M | 5.74M |
| Cost of Revenue | 2.08M | 2.65M | 3.63M | 4.36M | 5.11M |
| Gross Profit | 4.13M | 3.81M | 3.29M | 925.10K | 628.50K |
| SG&A Expenses | 4.29M | 4.55M | 4.70M | 4.78M | 4.46M |
| Depreciation & Amortization | 127.40K | 187.30K | 245.00K | 301.10K | 304.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.28M | 9.22M | 10.53M | 11.43M | 11.91M |
| Operating Income | -2.07M | -2.77M | -3.61M | -6.14M | -6.17M |
| Income Before Tax | -2.07M | -2.77M | -3.71M | -10.97M | -15.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.07 | -2.77 | -3.71 | -10.97 | -15.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.07M | -2.77M | -3.71M | -10.97M | -15.38M |
| EBIT | -2.07M | -2.77M | -3.61M | -6.14M | -6.17M |
| EBITDA | -1.94M | -2.58M | -3.37M | -5.84M | -5.87M |
| EPS Basic | -0.36 | -0.48 | -0.64 | -1.98 | -95.08 |
| Normalized Basic EPS | -0.22 | -0.30 | -0.39 | -0.69 | -36.96 |
| EPS Diluted | -0.39 | -0.51 | -0.67 | -1.98 | -95.08 |
| Normalized Diluted EPS | -0.24 | -0.32 | -0.41 | -0.69 | -36.96 |
| Average Basic Shares Outstanding | 23.01M | 23.01M | 23.04M | 22.91M | 17.26M |
| Average Diluted Shares Outstanding | 24.20M | 24.20M | 24.23M | 22.91M | 17.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |